Inactive Instrument
Precision Therapeutics Inc Stock Nasdaq
Stocks
US74033P1003
Biotechnology & Medical Research
| Market Cap | 124M 107M 100M 91.47M 171M 11.69B 172M 1.18B 459M 5.99B 464M 454M 19.32B | P/E 2024 |
-0.35x | P/E 2025 | -0.53x |
|---|---|---|---|---|---|
| Enterprise Value | 115M 98.65M 92.67M 84.72M 159M 10.82B 159M 1.1B 425M 5.55B 430M 421M 17.9B | EV / Sales 2024 |
4.23x | EV / Sales 2025 | 121x |
| Free-Float |
94.39% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript : Precision Therapeutics Inc
| 1 day | -7.56% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 2026-02-08 | |
| Director of Finance/CFO | - | 2026-04-15 | |
Kyle Okamoto
PSD | President | - | 2026-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Daniel Handley
BRD | Director/Board Member | 66 | 2020-02-18 |
Charles L. Nuzum
CHM | Chairman | 78 | 2026-02-08 |
| Director/Board Member | 60 | 2020-07-08 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -7.56% | -8.33% | - | - | 124M | ||
| -2.54% | -2.84% | -1.90% | +14.52% | 48.93B | ||
| -0.40% | +1.03% | +439.20% | +499.20% | 45.01B | ||
| -1.42% | +2.30% | +45.46% | +19.36% | 44.07B | ||
| -1.22% | -2.31% | +12.40% | +71.48% | 40.73B | ||
| +0.53% | -1.36% | +16.04% | +48.23% | 33.52B | ||
| -0.21% | +9.14% | - | - | 17.77B | ||
| -0.35% | -1.56% | +22.59% | +116.19% | 16.5B | ||
| -1.01% | +0.50% | +15.83% | +27.98% | 14.67B | ||
| -1.65% | -1.03% | +77.75% | +37.63% | 13.77B | ||
| Average | -1.58% | +0.53% | +78.42% | +104.33% | 30.55B | |
| Weighted average by Cap. | -1.04% | +0.11% | +94.86% | +122.11% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.62M 1.4M 1.31M 1.2M 2.25M 153M 2.25M 15.53M 6.02M 78.63M 6.1M 5.96M 254M | 125K 108K 101K 92.66K 173K 11.84M 174K 1.2M 465K 6.07M 470K 460K 19.57M |
| Net income | -12.66M -10.91M -10.25M -9.37M -17.52M -1.2B -17.58M -121M -46.96M -613M -47.55M -46.52M -1.98B | -233M -201M -189M -172M -323M -22.03B -324M -2.23B -864M -11.29B -875M -856M -36.41B |
| Net Debt | 1.4M 1.2M 1.13M 1.03M 1.93M 132M 1.94M 13.35M 5.18M 67.62M 5.24M 5.13M 218M | -9.12M -7.86M -7.38M -6.75M -12.63M -862M -12.67M -87.27M -33.83M -442M -34.26M -33.51M -1.43B |
Employees
-
















